For example, stratification of a DLB group with coexisting AD pathology in the CSF demonstrated higher levels of the glial marker YKL-40 [39], suggesting that the increase is related to AD neurodegeneration. This evidence concerns the gene CHI3L1 and Alzheimer disease.